847 Mrv0541 02231215032D 4 3 0 0 0 0 999 V2000 4.2366 0.4620 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 2.0931 0.0495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8076 0.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5220 0.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 4 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 M END > DB00847 > drugbank > NCCS > InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2 > UFULAYFCSOUIOV-UHFFFAOYSA-N > C2H7NS > 77.149 > 77.029919919 > 1 > 11 > 0.9987657568386272 > 8.651056413998477 > 1 > 2 > 0 > 0 > 2-aminoethane-1-thiol > 0.01 > -0.41661316428888157 > -0.52 > 0 > 1 > 0 > 1 > 9.422940354198866 > 10.398577468244163 > 26.02 > 22.393700000000003 > 1 > 1 > 2.35e+01 g/l > tetrahydrofolic acid > 1 > DB00847 > APRD00896 > approved; investigational > Cysteamine > 2-amino-1-ethanethiol; 2-amino-ethanethiol; 2-aminoethanethiol; beta-aminoethanethiol; beta-Mercaptoethylamine; Cysteamine; MEA; Mercaptamina; Mercaptamine; Mercaptaminum; Thioethanolamine; β-aminoethylthiol; β-MEA > Cystadrops; Cystagon; Cystaran; PROCYSBI Delayed-release; Procysbi > Cystagon; Cystaran; Procysbi > Cysteamine bitartrate; Cysteamine hydrochloride $$$$